Company Team

Company Team

Co-Founder & President

Mr. Lei Chen

Mr. Lei Chen


  • 20+ yrs of operating management experience and resource integration ability in pharmaceutical enterprises
  • Former Executive Vice president/Director of Hunan Jinsha Pharmaceutical Co., LTD., and led the listing of Jinsha Pharmaceutical
  • Shareholders and directors of multiple proposed listed companies

Co-Founder & CEO

Dr. Sean Li

Dr. Sean Li


  • 30+ yrs experience in  peptide chemistry and  biology
  • 10 yrs CRO experience in  peptide technology and  services. Former Exec. Director of Peptide  Technology and Services in  WuXi AppTec
  • Ph.D. in Chemistry from  Peking University; Postdoc  at Purdue, University of  Maryland and Osaka  University

Co-Founder & Senior Vice President

Mr. Huanzhang Gong

Mr. Huanzhang Gong


  • 20+ yrs of experience in pharmaceutical enterprise operation and management
  • Former General Manager of Hunan Jinsha Pharmaceutical Trading Company;Sales Manager of Zhuhai Tianda Pharmaceutical
  • Has invested in Jinsha Pharmaceutical, Anxin Biological, Huateng Pharmaceutical, Yuanxu Optoelectronics and other companies (financial investment)

Vice President

Mr.Xinbo Wang

Mr.Xinbo Wang


  • Former R&D Director of Chengdu Shengnuo
  • Former Director of Peptide Technology and Service Department at WuXi AppTec
  • Former R&D manager of Kingsrui Peptide Department

Vice President

Dr. Qiuyun Dai

Dr. Qiuyun Dai


  • Ph.D. degree in Chemistry and postdoctoral fellow in Beijing Institute of Biotechnology and the Department of Chemistry and Biochemistry at the University of Notre Dame
  • Former vice president of Discovery Chemistry of Shanghai ChemPartner, director of peptide division, principal investigator (professor) and doctoral supervisor of Beijing Institute of Biotechnology
  • He completed a number of clinical or preclinical studies of Class I innovative drugs, and is familiar with peptide and small molecule drug design, synthesis (including large scale manufacture),quality study, pharmacology and drug application process

Vice President, R&D Strategy

Dr. Yantao He

Dr. Yantao He


  • He is a highly experienced peptide medicinal chemist with over 20 years of expertise in academia and the pharmaceutical industry
  • He has served as Senior Director of Peptide Chemistry at GeneScience Pharmaceuticals and played key roles in drug discovery at Neurocrine Biosciences, Novo Nordisk Research Center Indianapolis (NNRCI), and Indiana University School of Medicine
  • He holds a Ph.D. from Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences

Senior Director, Executive Director

Dr. Yilong Li

Dr. Yilong Li


  • 10+ years of peptide drug  development experience,  team leading experience  from target/indication  selection to PCC/IND
  • Former Senzior Principal Scientist at Jiangsu Hengrui  Medicine Co.,Senior  Scientist at Creative  Peptides, Development  Scientist PolyPeptide Group
  • Ph.D. in Pharmaceutical  Sciences at USC

Senior Director of Business Development

Dr.Jin Zhang

Dr.Jin Zhang


  • She was the Associate Director of Business Development at Exelixis
  • She was the Investment Director at Foothill Ventures and led the investment into innovative startups in life science
  • She was the Project and Account Manager at LakePharma
  • M.D. in clinical medicine from Nantong Medical School and Ph.D. in Pharmacology from UCLA

 

Director of Global Business Development

Dr. Timo  Xu

Dr. Timo Xu


  • Ph.D. in Chemistry from the National University of Singapore
  • Senior Scientist at SRI International and a Boston-based biotech startup founded by Prof. Bob Langer from MIT
  • Postdoctoral researcher at Tsinghua University, Novo Nordisk, and the University of Utah
  • Over 10 years of experience in peptide chemistry, total chemical synthesis of proteins, peptide drug screening, and peptide conjugate drug preparation
  • Published papers as the first author in top tier journals such as Nature Chemistry and Cell Discovery, with nearly 700 citations

Dr. Rumin Zhang

Dr. Rumin Zhang


  • Currently CSO at Global Health Drug Discovery Institute
  • Formerly, Vice President of Volastra Therapeutics, Vice President of Raphael Pharmaceuticals and Senior Principal Scientist of Merck and Schering-Plough in the United States
  • Ph.D. in Biochemistry and Biophysics from State University of New York at Buffalo
  • 35+ yrs of successful multidisciplinary drug discovery research experience
< 1 > proceed page